David Robinson

11.1k total citations · 4 hit papers
135 papers, 8.0k citations indexed

About

David Robinson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cognitive Neuroscience. According to data from OpenAlex, David Robinson has authored 135 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Pulmonary and Respiratory Medicine, 39 papers in Oncology and 30 papers in Cognitive Neuroscience. Recurrent topics in David Robinson's work include Prostate Cancer Treatment and Research (51 papers), Prostate Cancer Diagnosis and Treatment (49 papers) and Global Cancer Incidence and Screening (29 papers). David Robinson is often cited by papers focused on Prostate Cancer Treatment and Research (51 papers), Prostate Cancer Diagnosis and Treatment (49 papers) and Global Cancer Incidence and Screening (29 papers). David Robinson collaborates with scholars based in Sweden, United States and United Kingdom. David Robinson's co-authors include Michael E. Goldberg, EJ Balthazar, Alec J. Megibow, John H.C. Ranson, Henrik Møller, Pär Stattin, Gregory B. Stanton, M. Catherine Bushnell, C. Kertzman and Steven E. Petersen and has published in prestigious journals such as Nature, JAMA and Journal of Clinical Oncology.

In The Last Decade

David Robinson

132 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acute pancreatitis: value of CT in establishing prognosis.

1990 1.1k citations David Robinson et al. profile →
Parietal association cortex in the primate: sensory mechanisms and behavioral modulations

1978 631 citations David Robinson et al. profile →
Behavioral enhancement of visual responses in monkey cerebral cortex. I. Modulation in posterior parietal cortex related to selective visual attention

1981 624 citations David Robinson et al. profile →
Shared neural control of attentional shifts and eye movements

1996 503 citations David Robinson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Robinson Sweden	44	3.5k	1.9k	1.7k	1.7k	618	135	8.0k
Joseph R. Simpson United States	50	2.1k 0.6×	1.6k 0.8×	2.0k 1.1×	2.3k 1.4×	771 1.2×	147	10.0k
Martin Klein Netherlands	58	2.1k 0.6×	1.0k 0.5×	1.0k 0.6×	3.3k 2.0×	663 1.1×	252	10.6k
Cai Grau Denmark	60	1.5k 0.4×	2.5k 1.3×	3.1k 1.8×	4.3k 2.5×	651 1.1×	323	12.7k
Jaap C. Reijneveld Netherlands	52	2.8k 0.8×	1.1k 0.6×	446 0.3×	2.2k 1.3×	1.1k 1.8×	214	9.4k
Mary Lou Smith Canada	46	2.9k 0.8×	2.1k 1.1×	431 0.2×	593 0.4×	430 0.7×	282	9.3k
Bauke M. de Jong Netherlands	50	1.5k 0.4×	711 0.4×	2.0k 1.1×	1.6k 0.9×	2.2k 3.5×	304	8.1k
Gary D. Hutchins United States	55	752 0.2×	1.1k 0.6×	861 0.5×	988 0.6×	1.4k 2.3×	245	9.4k
Bernd J. Krause Germany	52	999 0.3×	1.7k 0.9×	1.0k 0.6×	4.6k 2.7×	811 1.3×	257	9.4k
Françis Brunelle France	62	1.9k 0.5×	627 0.3×	4.1k 2.3×	1.8k 1.1×	1.5k 2.4×	319	12.6k
Peter J. Ell United Kingdom	54	682 0.2×	2.1k 1.1×	1.2k 0.7×	1.7k 1.0×	725 1.2×	157	7.8k

Countries citing papers authored by David Robinson

Since Specialization

Citations

This map shows the geographic impact of David Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Robinson more than expected).

Fields of papers citing papers by David Robinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Robinson. The network helps show where David Robinson may publish in the future.

Co-authorship network of co-authors of David Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of David Robinson. A scholar is included among the top collaborators of David Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Robinson. David Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stattin, Pär, Xiwu Lin, Florence Lefresne, et al.. (2024). Population‐based study of disease trajectory after radical treatment for high‐risk prostate cancer. British Journal of Urology. 134(1). 96–102.

Corsini, Christian, Oskar Bergengren, Stefan Carlsson, et al.. (2024). Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study. European Urology Oncology. 7(3). 605–613. 14 indexed citations

Hemelrijck, Mieke Van, Eugenio Ventimiglia, David Robinson, et al.. (2022). Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males. BMC Medical Informatics and Decision Making. 22(1). 35–35. 15 indexed citations

Westerberg, Marcus, Peter C. Albertsen, Johan Styrke, et al.. (2022). Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy. PLoS ONE. 17(11). e0277784–e0277784. 2 indexed citations

Lissbrant, Ingela Franck, Eugenio Ventimiglia, David Robinson, et al.. (2018). Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden. Scandinavian Journal of Urology. 52(2). 143–150. 12 indexed citations

Pettersson, Andreas, David Robinson, Hans Garmo, Lars Holmberg, & P. Stattin. (2017). Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study. Annals of Oncology. 29(2). 377–385. 76 indexed citations

Folkvaljon, Yasin, Per Nilsson, David Robinson, et al.. (2016). Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study. Scandinavian Journal of Urology. 50(5). 338–345. 15 indexed citations

Loeb, Stacy, Yasin Folkvaljon, Mats Lambe, et al.. (2015). Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma. JAMA. 313(24). 2449–2449. 66 indexed citations

Ohmann, Erin, Stacy Loeb, David Robinson, et al.. (2014). Nationwide, population-based study of prostate cancer stage migration between and within clinical risk categories. Scandinavian Journal of Urology. 48(5). 426–435. 25 indexed citations

10.

Robinson, David, et al.. (2013). Use of 5 -reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study. BMJ. 346(jun18 2). f3406–f3406. 24 indexed citations

11.

Loeb, Stacy, Linda Drevin, David Robinson, et al.. (2012). Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study. Cancer Causes & Control. 24(2). 383–390. 11 indexed citations

12.

Møller, Henrik, Fredrik Sandin, Freddie Bray, et al.. (2010). Breast cancer survival in England, Norway and Sweden: a population‐based comparison. International Journal of Cancer. 127(11). 2630–2638. 64 indexed citations

13.

Robinson, David, Lars Holmberg, & Henrik Møller. (2008). The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ. British Journal of Cancer. 99(4). 611–615. 10 indexed citations

14.

Powles, Thomas, David Robinson, Jonathan Shamash, et al.. (2007). The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Annals of Oncology. 19(3). 443–447. 85 indexed citations

15.

Roychoudhuri, Rahul, David Robinson, Venkata Putcha, et al.. (2007). Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer. 7(1). 9–9. 138 indexed citations

16.

Silcocks, P & David Robinson. (2007). Simulation modelling to validate the flow method for estimating completeness of case ascertainment by cancer registries. Journal of Public Health. 29(4). 455–462. 13 indexed citations

17.

Aus, Gunnar, David Robinson, Johan Rosell, Gabriel Sandblom, & Eberhard Varenhorst. (2005). Survival in prostate carcinoma—Outcomes from a prospective, population‐based cohort of 8887 men with up to 15 years of follow‐up. Cancer. 103(5). 943–951. 42 indexed citations

18.

Roychoudhuri, Rahul, Helen Evans, David Robinson, & Henrik Møller. (2004). Radiation-induced malignancies following radiotherapy for breast cancer. British Journal of Cancer. 91(5). 868–872. 133 indexed citations

19.

Evans, Helen, Cathryn M. Lewis, David Robinson, et al.. (2001). Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. British Journal of Cancer. 84(3). 435–440. 103 indexed citations

20.

Kertzman, C., David Robinson, & Irene Litvan. (1990). Effects of Physostigmine on Spatial Attention in Patients With Progressive Supranuclear Palsy. Archives of Neurology. 47(12). 1346–1350. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact